237 related articles for article (PubMed ID: 8881754)
1. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes.
Singer NG; Richardson BC; Powers D; Hooper F; Lialios F; Endres J; Bott CM; Fox DA
Immunology; 1996 Aug; 88(4):537-43. PubMed ID: 8881754
[TBL] [Abstract][Full Text] [Related]
2. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
[TBL] [Abstract][Full Text] [Related]
3. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on gamma-interferon activated keratinocytes.
Singer NG; Mitra R; Lialios F; Richardson BC; Marks RM; Pesando JM; Fox DA; Nickoloff BJ
Immunol Lett; 1997 Jun; 58(1):9-14. PubMed ID: 9436462
[TBL] [Abstract][Full Text] [Related]
4. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
Osorio LM; Garcia CA; Jondal M; Chow SC
Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
[TBL] [Abstract][Full Text] [Related]
5. Relevance of CD6-mediated interactions in T cell activation and proliferation.
Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
[TBL] [Abstract][Full Text] [Related]
6. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
7. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
[TBL] [Abstract][Full Text] [Related]
8. Modulation of CD6 function through interaction with Galectin-1 and -3.
Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
[TBL] [Abstract][Full Text] [Related]
9. Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand.
Bowen MA; Patel DD; Li X; Modrell B; Malacko AR; Wang WC; Marquardt H; Neubauer M; Pesando JM; Francke U
J Exp Med; 1995 Jun; 181(6):2213-20. PubMed ID: 7760007
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
[TBL] [Abstract][Full Text] [Related]
11. Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells.
Zimmerman AW; Joosten B; Torensma R; Parnes JR; van Leeuwen FN; Figdor CG
Blood; 2006 Apr; 107(8):3212-20. PubMed ID: 16352806
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and regulation of CD6 on T-cell subsets revealed by monoclonal antibody (MAb) CH11.
Bank I; Dardik R; Levy V; Goldstein I; Shoham J
Hybridoma; 2001 Apr; 20(2):75-84. PubMed ID: 11394533
[TBL] [Abstract][Full Text] [Related]
13. Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH; Prohaska SS; Santoro JC; Robinson HL; Parnes JR
J Immunol; 1995 Nov; 155(10):4739-48. PubMed ID: 7594475
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of CD6: properties of two distinct epitopes involved in T cell activation.
Swack JA; Gangemi RM; Rudd CE; Morimoto C; Schlossman SF; Romain PL
Mol Immunol; 1989 Nov; 26(11):1037-49. PubMed ID: 2481822
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
16. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
17. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
Nair P; Melarkode R; Rajkumar D; Montero E
Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
[TBL] [Abstract][Full Text] [Related]
18. CD318 is a ligand for CD6.
Enyindah-Asonye G; Li Y; Ruth JH; Spassov DS; Hebron KE; Zijlstra A; Moasser MM; Wang B; Singer NG; Cui H; Ohara RA; Rasmussen SM; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6912-E6921. PubMed ID: 28760953
[TBL] [Abstract][Full Text] [Related]
19. Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
Robinson WH; Neuman de Vegvar HE; Prohaska SS; Rhee JW; Parnes JR
Eur J Immunol; 1995 Oct; 25(10):2765-9. PubMed ID: 7589069
[TBL] [Abstract][Full Text] [Related]
20. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
Gangemi RM; Swack JA; Gaviria DM; Romain PL
J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
